X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11256) 11256
Government Document (60) 60
Book Chapter (56) 56
Dissertation (19) 19
Publication (16) 16
Magazine Article (14) 14
Conference Proceeding (4) 4
Newspaper Article (3) 3
Book / eBook (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9301) 9301
female (7082) 7082
brca1 (4828) 4828
breast cancer (4811) 4811
oncology (4772) 4772
breast neoplasms - genetics (4740) 4740
mutation (4296) 4296
brca1 protein - genetics (4211) 4211
cancer (3215) 3215
middle aged (3047) 3047
adult (2927) 2927
genetic aspects (2557) 2557
brca1 protein (2427) 2427
genes, brca1 (2421) 2421
ovarian neoplasms - genetics (2259) 2259
genetics & heredity (2128) 2128
ovarian cancer (2102) 2102
brca2 protein - genetics (2078) 2078
genetic predisposition to disease (2022) 2022
aged (1954) 1954
ovarian-cancer (1737) 1737
animals (1649) 1649
risk factors (1642) 1642
research (1639) 1639
genes (1637) 1637
brca2 protein (1621) 1621
dna repair (1598) 1598
brca1 protein - metabolism (1572) 1572
risk (1467) 1467
biochemistry & molecular biology (1459) 1459
male (1444) 1444
brca2 (1402) 1402
dna damage (1371) 1371
breast-cancer (1366) 1366
cell biology (1349) 1349
breast neoplasms - pathology (1325) 1325
genes, brca2 (1289) 1289
mutations (1289) 1289
women (1280) 1280
tumors (1260) 1260
skin and connective tissue diseases (1172) 1172
gene mutations (1113) 1113
proteins (1091) 1091
genetics (1040) 1040
germ-line mutation (1037) 1037
deoxyribonucleic acid--dna (1032) 1032
mice (1032) 1032
expression (1019) 1019
health aspects (1017) 1017
cell line, tumor (1001) 1001
gene expression (996) 996
genetic testing (976) 976
analysis (960) 960
gene (957) 957
neoplasm proteins - genetics (941) 941
homologous recombination (926) 926
dna (915) 915
prognosis (907) 907
transcription factors - genetics (877) 877
breast neoplasms - metabolism (834) 834
breast (820) 820
repair (781) 781
endocrine system diseases (774) 774
medicine & public health (767) 767
heterozygote (737) 737
aged, 80 and over (729) 729
protein (724) 724
chemotherapy (721) 721
gene expression regulation, neoplastic (705) 705
susceptibility (704) 704
multidisciplinary sciences (703) 703
germline mutations (697) 697
pedigree (686) 686
research article (668) 668
dna mutational analysis (655) 655
care and treatment (648) 648
genetic research (648) 648
breast neoplasms - epidemiology (647) 647
survival (637) 637
genomics (624) 624
cell cycle (610) 610
phosphorylation (610) 610
genetic screening (602) 602
breast neoplasms - diagnosis (585) 585
families (581) 581
cells (575) 575
apoptosis (565) 565
dna-binding proteins - genetics (559) 559
medicine (555) 555
ovarian neoplasms - pathology (541) 541
oncology, experimental (540) 540
pathology (540) 540
polymerase chain reaction (534) 534
cancer research (528) 528
dna methylation (527) 527
case-control studies (526) 526
genomes (525) 525
phenotype (523) 523
identification (522) 522
carcinoma (521) 521
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11235) 11235
Japanese (71) 71
Chinese (62) 62
French (57) 57
German (32) 32
Russian (28) 28
Polish (14) 14
Spanish (11) 11
Portuguese (10) 10
Dutch (8) 8
Bulgarian (6) 6
Croatian (5) 5
Hebrew (5) 5
Czech (4) 4
Italian (3) 3
Norwegian (3) 3
Hungarian (2) 2
Swedish (2) 2
Breton (1) 1
Danish (1) 1
Icelandic (1) 1
Korean (1) 1
Persian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature cell biology, ISSN 1476-4679, 2018, Volume 20, Issue 8, pp. 954 - 965
.... We identified two previously uncharacterized proteins, C2Oorf196 and FAM35A, whose inactivation confers strong PARP-inhibitor resistance... 
PATHWAY CHOICE | STRAND BREAK REPAIR | RESECTION | DAMAGE-RESPONSE | 53BP1 | CLASS-SWITCH RECOMBINATION | FANCONI-ANEMIA | DIFFERENTIAL EXPRESSION ANALYSIS | POLYMERASE-ZETA | TELOMERES | CELL BIOLOGY | Osteosarcoma - drug therapy | Mad2 Proteins - metabolism | Humans | Multiprotein Complexes | Ovarian Neoplasms - pathology | Bone Neoplasms - pathology | DNA Breaks, Double-Stranded | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Ovarian Neoplasms - genetics | Telomere-Binding Proteins - genetics | DNA End-Joining Repair | HEK293 Cells | Female | Bone Neoplasms - genetics | Ovarian Neoplasms - metabolism | Bone Neoplasms - drug therapy | BRCA1 Protein - deficiency | Telomere-Binding Proteins - metabolism | Ovarian Neoplasms - drug therapy | Osteosarcoma - metabolism | DNA-Binding Proteins | Tumor Suppressor p53-Binding Protein 1 - metabolism | Recombinational DNA Repair | Tumor Suppressor p53-Binding Protein 1 - genetics | Cisplatin - pharmacology | Breast Neoplasms - drug therapy | Proteins - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Breast Neoplasms - genetics | Proteins - metabolism | Breast Neoplasms - pathology | Mad2 Proteins - genetics | Cell Line, Tumor | Mice | Osteosarcoma - genetics | Cell Cycle Proteins | Osteosarcoma - pathology | Care and treatment | DNA | Cancer cells | Breast cancer | Genetic aspects | Research | Gene expression | Single-stranded DNA | DNA damage | Homologous recombination | Poly(ADP-ribose) | Homology | Genomes | Inactivation | Proteins | Ribose | Null cells | Deoxyribonucleic acid--DNA | BRCA2 protein | CRISPR | Deactivation | BRCA1 protein | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Oligosaccharides | Double-strand break repair | Screens | Cisplatin | Inhibitors | Prostate | Viability | Tumors | Telomere-Binding Proteins / metabolism | Osteosarcoma / genetics | Telomere-Binding Proteins / genetics | BRCA1 Protein / genetics | Cellular Biology | Genetics | Proteins / genetics | Osteosarcoma / drug therapy | Ovarian Neoplasms / genetics | Mad2 Proteins / genetics | Proteins / metabolism | Breast Neoplasms / drug therapy | Breast Neoplasms / metabolism | Tumor Suppressor p53-Binding Protein 1 / genetics | BRCA1 Protein / deficiency | Ovarian Neoplasms / metabolism | Mad2 Proteins / metabolism | Breast Neoplasms / pathology | Bone Neoplasms / genetics | Ovarian Neoplasms / pathology | Bone Neoplasms / pathology | Life Sciences | Bone Neoplasms / drug therapy | Ovarian Neoplasms / drug therapy | Osteosarcoma / metabolism | Biochemistry, Molecular Biology | Breast Neoplasms / genetics | Drug Resistance, Neoplasm / genetics | Osteosarcoma / pathology | Bone Neoplasms / metabolism | Poly(ADP-ribose) Polymerase Inhibitors / pharmacology | Cisplatin / pharmacology | Molecular biology | Tumor Suppressor p53-Binding Protein 1 / metabolism | Cancer
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 353 - 14
Mucosal melanoma is a rare and poorly characterized subtype of human melanoma. Here we perform a cross-species analysis by sequencing tumor-germline pairs from... 
POINT MUTATIONS | CANCER PATIENTS | BREAST-CANCER | MUTATIONAL PROCESSES | ARRAY-CGH | MULTIDISCIPLINARY SCIENCES | COPY NUMBER | TUMOR | OVARIAN-CANCER | MOUSE MODELS | REVEALS | Proto-Oncogene Proteins c-mdm2 - genetics | Cadherins - metabolism | Humans | Carcinogenesis - metabolism | DNA Copy Number Variations | Germ-Line Mutation | Cadherins - genetics | Neoplasm Proteins - genetics | Mouth Neoplasms - genetics | Protein-Serine-Threonine Kinases - metabolism | PTEN Phosphohydrolase - genetics | Tumor Suppressor Proteins - metabolism | Membrane Proteins - genetics | Carcinogenesis - genetics | Cell Cycle Proteins - metabolism | Melanoma - pathology | Mucous Membrane - pathology | GTP Phosphohydrolases - metabolism | GTP Phosphohydrolases - genetics | Microtubule-Associated Proteins - genetics | Species Specificity | Microtubule-Associated Proteins - metabolism | Gene Expression Regulation, Neoplastic | Mouth Neoplasms - metabolism | Receptor-Like Protein Tyrosine Phosphatases, Class 3 - genetics | Neoplasm Proteins - metabolism | Tumor Suppressor Protein p53 - genetics | Melanoma - genetics | BRCA1 Protein - metabolism | Tumor Suppressor Proteins - genetics | Cell Cycle Proteins - genetics | Membrane Proteins - metabolism | Proto-Oncogene Proteins c-mdm2 - metabolism | Melanoma - metabolism | Skin Neoplasms - pathology | Neoplasm Recurrence, Local | Protein-Serine-Threonine Kinases - genetics | Tumor Suppressor Protein p53 - metabolism | PTEN Phosphohydrolase - metabolism | Mucous Membrane - metabolism | Skin Neoplasms - metabolism | Carcinogenesis - pathology | BRCA1 Protein - genetics | Animals | BRCA2 Protein - metabolism | Receptor-Like Protein Tyrosine Phosphatases, Class 3 - metabolism | Skin Neoplasms - genetics | Dogs | Horses | Mouth Neoplasms - pathology | BRCA2 Protein - genetics | BRCA2 protein | MDM2 protein | BRCA1 protein | Copy number | p53 Protein | Mucosa | Melanoma | Data processing | Breast cancer | Metastases | Heterogeneity | Human performance | Tumorigenesis | Mutation | Comparative analysis | Species | PTEN protein | Tumors
Journal Article
Cancer cell, ISSN 1535-6108, 2007, Volume 11, Issue 2, pp. 103 - 105
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 10, pp. 1721 - 1730
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 10, pp. 1086 - 1095
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 20, pp. 3925 - 3932
... protein Hox‐B13 ( HOXB13 ) gene on chromosome 17 through linkage analysis. The HOXB13 G84E mutation typically occurs on a common haplotype consistent with a founder... 
prostate cancer | germline variants | multiple primary malignant neoplasms | genetic testing | gene panel | GENOMICS | ONCOLOGY | COLORECTAL-CANCER | DNA | HOXB13 G84E MUTATION | RISK | LYNCH SYNDROME | Humans | Middle Aged | Male | Mutation, Missense | Checkpoint Kinase 2 - genetics | Prostatic Neoplasms - genetics | DNA Mutational Analysis | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Germ-Line Mutation | Adult | RNA Helicases - genetics | Neoplastic Syndromes, Hereditary - genetics | Neoplasms, Second Primary - genetics | Nuclear Proteins - genetics | Fanconi Anemia Complementation Group N Protein | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Genetic Predisposition to Disease | Neoplastic Syndromes, Hereditary - diagnosis | DNA-Binding Proteins - genetics | Fanconi Anemia Complementation Group Proteins | Sequence Analysis, DNA | Homeodomain Proteins - genetics | MutL Protein Homolog 1 - genetics | Age of Onset | Aged | Ataxia Telangiectasia Mutated Proteins - genetics | BRCA2 Protein - genetics | Care and treatment | Genetic aspects | Research | Gene mutations | Genetic variation | Prostate cancer | Fibroblast growth factor | Genes | DNA damage | Homology | Malignancy | Criteria | DNA repair | Genetic screening | Homeobox | DNA helicase | Proteins | Ataxia | Genetics | Deoxyribonucleic acid--DNA | Fibroblast growth factor receptor 3 | BRCA2 protein | CHK2 protein | Nucleotide sequence | BRCA1 protein | MLH1 protein | Health risks | Protein C | Breast cancer | Medical screening | Patients | Medical prognosis | Men | Ataxia telangiectasia mutated protein | Mutation | Prostate | Cancer | Fibroblast growth factor receptors
Journal Article
by Koboldt, Daniel C and Fulton, Robert S and McLellan, Michael D and Schmidt, Heather and Kalicki-Veizer, Joelle and McMichael, Joshua F and Fulton, Lucinda L and Dooling, David J and Ding, Li and Mardis, Elaine R and Wilson, Richard K and Ally, Adrian and Balasundaram, Miruna and Butterfield, Yaron S. N and Carlsen, Rebecca and Carter, Candace and Chu, Andy and Chuah, Eric and Chun, Hye-Jung E and Coope, Robin J. N and Dhalla, Noreen and Guin, Ranabir and Hirst, Carrie and Hirst, Martin and Holt, Robert A and Lee, Darlene and Li, Haiyan I and Mayo, Michael and Moore, Richard A and Mungall, Andrew J and Pleasance, Erin and Robertson, A. Gordon and Schein, Jacqueline E and Shafiei, Arash and Sipahimalani, Payal and Slobodan, Jared R and Stoll, Dominik and Tam, Angela and Thiessen, Nina and Varhol, Richard J and Wye, Natasja and Zeng, Thomas and Zhao, Yongjun and Birol, Inanc and Jones, Steven J. M and Marra, Marco A and Cherniack, Andrew D and Saksena, Gordon and Onofrio, Robert C and Pho, Nam H and Carter, Scott L and Schumacher, Steven E and Tabak, Barbara and Hernandez, Bryan and Gentry, Jeff and Nguyen, Huy and Crenshaw, Andrew and Ardlie, Kristin and Beroukhim, Rameen and Winckler, Wendy and Getz, Gad and Gabriel, Stacey B and Meyerson, Matthew and Chin, Lynda and Kucherlapati, Raju and Hoadley, Katherine A and Auman, J. Todd and Fan, Cheng and Turman, Yidi J and Shi, Yan and Li, Ling and Topal, Michael D and He, Xiaping and Chao, Hann-Hsiang and Prat, Aleix and Silva, Grace O and Iglesia, Michael D and Zhao, Wei and Usary, Jerry and Berg, Jonathan S and Adams, Michael and Booker, Jessica and Wu, Junyuan and Gulabani, Anisha and Bodenheimer, Tom and Hoyle, Alan P and Simons, Janae V and Soloway, Matthew G and Mose, Lisle E and Jefferys, Stuart R and Balu, Saianand and Parker, Joel S and Hayes, D. Neil and Perou, Charles M and Malik, Simeen and Mahurkar, Swapna and Shen, Hui and Weisenberger, Daniel J and Triche Jr, Timothy and Lai, Phillip H and ... and The Cancer Genome Atlas Network and Canc Genome Atlas Network and Cancer Genome Atlas Network
Nature (London), ISSN 1476-4687, 2012, Volume 490, Issue 7418, pp. 61 - 70
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays... 
PATHWAYS | TARGET | BASAL-LIKE | SUPPRESSOR | PIK3CA GENE | SUBTYPES | MULTIDISCIPLINARY SCIENCES | HIGH-FREQUENCY | LUMINAL-B | CANCER | MUTATIONAL EVOLUTION | GATA3 Transcription Factor - genetics | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Genomics | Humans | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Gene Expression Profiling | Breast Neoplasms - metabolism | Ovarian Neoplasms - genetics | DNA Methylation | DNA Mutational Analysis | Female | Genes, BRCA1 | Genes, Neoplasm - genetics | Breast Neoplasms - classification | RNA, Messenger - genetics | Retinoblastoma Protein - metabolism | DNA Copy Number Variations - genetics | Genes, p53 - genetics | Mutation - genetics | Genetic Heterogeneity | Genome, Human - genetics | Phosphatidylinositol 3-Kinases - genetics | Exome - genetics | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Genes, erbB-2 - genetics | Proteomics | Protein Array Analysis | RNA, Neoplasm - genetics | MAP Kinase Kinase Kinase 1 - genetics | MicroRNAs - genetics | Breast tumors | Gene mutations | Oncology, Experimental | Genetic aspects | Research | Identification and classification | Cancer | Proteins | DNA methylation | Genetics | Breast cancer | Mutation | Càncer de mama | Oncologia | Oncology | Gene expression | Expressió gènica | Genòmica
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2013, Volume 105, Issue 10, pp. 694 - 700
Journal Article